Inga Peter, PhD Email Inga Peter
-
- Position
- PROFESSOR | Genetics and Genomic Sciences
-
- Language
- English
Dr. Peter is Vice Chair of the Department of Genetics and Genomic Sciences, a Professor of Genetics and Genomic Sciences, and a faculty member of the Icahn Genomics Institute.
She received her PhD in Genetic Epidemiology from Tel Aviv University, Israel and completed a postdoctoral training at Tufts University while working on the Framingham Heart Study.
Dr. Peter is the Associate Director of the PhD Program in Clinical Research and Director of the Institutional Early Career Development Program (KL2). She also leads the Mentoring Program in the Department of Genetics and Genomic Sciences and the Icahn Institute for Data Science and Genomic Technology.
Research:
Dr. Peter’s primary research focus is on the assessment of the role of genetics, genomics and the microbiome in the pathogenesis of complex disorders, with the focus on inflammatory bowel disease (IBD). Recently, she led numerous efforts to establish genetic, clinical and therapeutic link between IBD and Parkinson’s disease. These findings are now used to develop novel approaches to diagnose and treat these two seemingly unrelated diseases. She is also the Principal Investigator of the MECONIUM (Exploring MEChanisms Of disease traNsmission In Utero through the Microbiome) study, aimed to understand the effects of maternal IBD on the initial bacterial colonization and development of the immune system in the offspring. Dr. Peter also leads the first IBD prevention trial, Modulating Early Life micrObiome through DietarY Intervention in Crohn’s Disease with the goal to test if dietary intervention during pregnancy could facilitate the development of a healthy microbiome in babies born to mothers with IBD.
In addition to IBD research, Dr. Peter is the Principal Investigator on a series of genetic and systems pharmacology studies of cardiovascular, metabolic and renal comorbidies, as well as adverse effects associated with antiretroviral therapy, in persons living with HIV. She is also leading a project aimed to identify genetic predictors of non-syndromic craniosynostosis, one of the most common birth defects.
Research Topic
Cardiovascular, Genetics, Genomics, Human Genetics and Genetic Disorders, Inflammatory Bowel Disease (IBD), Microbiology
Multi-Disciplinary Training Area
Genetics and Genomic Sciences [GGS]
Education
MSc, Tel Aviv University
PhD, Tel Aviv University
Postdoc, Tufts University
Language
English
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Peter has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website.
Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.